AROS PHARMA ApS: Financial statements 2013
CVR: 32102816
AROS PHARMA ApS (CVR 32102816) has filed annual accounts for 2013. In 2013, the company reported a net result of DKK -3,900,963 compared with DKK -3,245,679 the year before. Equity amounted to DKK 255,158. The solvency ratio was 5.5%.
- Profit/Loss
- -3,900,963 kr.
- Equity
- 255,158 kr.
- Total Assets
- 4,622,151 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | - | -3.9 mio. | 255 t. | - |
| 2012 | - | - | -3.2 mio. | 4.2 mio. | - |
Find more companies like AROS PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
AROS PHARMA ApS has published its annual report for 2012. The net result was DKK -3,245,679.
As of April 5, 2013, Line Holten Reimer has joined the board of directors of AROS PHARMA ApS.
As of April 5, 2013, Ole Bitsch-Jensen has left the board of directors of AROS PHARMA ApS.
About AROS PHARMA ApS
AROS PHARMA ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2009 and dissolved in 2016. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 0 employees. In 2015, the company reported a net result of DKK -721,837 compared with DKK -2,904,493 the year before. Equity amounted to DKK -3,371,172.
